Elizabeth Gillespie

5.0k total citations
89 papers, 2.9k citations indexed

About

Elizabeth Gillespie is a scholar working on Infectious Diseases, Immunology and Molecular Biology. According to data from OpenAlex, Elizabeth Gillespie has authored 89 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Infectious Diseases, 20 papers in Immunology and 19 papers in Molecular Biology. Recurrent topics in Elizabeth Gillespie's work include Mast cells and histamine (18 papers), Infection Control in Healthcare (15 papers) and Medical Device Sterilization and Disinfection (10 papers). Elizabeth Gillespie is often cited by papers focused on Mast cells and histamine (18 papers), Infection Control in Healthcare (15 papers) and Medical Device Sterilization and Disinfection (10 papers). Elizabeth Gillespie collaborates with scholars based in United States, Australia and United Kingdom. Elizabeth Gillespie's co-authors include Lawrence M. Lichtenstein, L M Lichtenstein, Rhonda L. Stuart, Robert P. Schleimer, Christopher S. Henney, Despina Kotsanas, Marshall Plaut, Robert J. Levine, Stephen E. Malawista and Tony M. Korman and has published in prestigious journals such as Nature, Journal of Clinical Investigation and The Journal of Cell Biology.

In The Last Decade

Elizabeth Gillespie

88 papers receiving 2.6k citations

Peers

Countries citing papers authored by Elizabeth Gillespie

Since Specialization

Citations

This map shows the geographic impact of Elizabeth Gillespie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Gillespie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Gillespie more than expected).

Fields of papers citing papers by Elizabeth Gillespie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Gillespie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Gillespie. The network helps show where Elizabeth Gillespie may publish in the future.

Co-authorship network of co-authors of Elizabeth Gillespie

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Gillespie. A scholar is included among the top collaborators of Elizabeth Gillespie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Gillespie. Elizabeth Gillespie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Building Climate Change into Medical Education: A Society of General Internal Medicine Position Statement 2024 ·Journal of General Internal Medicine ·Arnab K. Ghosh, (unknown), Gaurab Basu, (unknown), Elizabeth Gillespie, (unknown), Sudarshan Krishnamurthy, (unknown), Erin N. Marcus, (unknown), (unknown), (unknown), (unknown)	3
2	Opportunities for Strengthening Climate Education for Clinical Health Professionals 2024 ·NAM Perspectives ·Jay Lemery, Terry O’Connor, Elizabeth Gillespie, (unknown), (unknown), (unknown), Rebecca Philipsborn, (unknown)	0
3	Performance of ICD-10-AM codes for quality improvement monitoring of hospital-acquired pneumonia in a haematology-oncology casemix in Victoria, Australia 2022 ·Health Information Management Journal ·(unknown), Elizabeth Gillespie, Karin Verspoor, Lisa Hall, (unknown)	2
4	Defining Opioid-related Problems Using a Health Care Safety Net Institution’s Inpatient Electronic Health Records: Limitations of Diagnosis-based Definitions 2022 ·Journal of Addiction Medicine ·Aziza Arifkhanova, José Tomás Prieto, Arthur J. Davidson, Alia Al‐Tayyib, (unknown), Emily M. Kraus, (unknown), Laura Jean Podewils, Seth Foldy, Elizabeth Gillespie, (unknown), Judith C. Shlay	5
5	Adenosine triphosphate bioluminescence to validate decontamination of endoscopes 2017 ·Journal of Hospital Infection ·Elizabeth Gillespie, William Sievert, Michael P. Swan, (unknown), (unknown), Rhonda L. Stuart	11
6	USING ADENOSINETRIPHOSPHATE BIOLUMINESCENCE TO VALIDATE DECONTAMINATION FOR DUODENOSCOPES. 2016 ·PubMed ·Elizabeth Gillespie, William Sievert, Michael P. Swan, (unknown), (unknown), Rhonda L. Stuart	4
7	A parainfluenza virus type 3 outbreak at a residential aged care facility: The role of microbiologic testing in early identification and antimicrobial stewardship 2016 ·American Journal of Infection Control ·(unknown), Elizabeth Gillespie, Rhonda L. Stuart	6
8	Using microfiber and steam technology to improve cleaning outcomes in an intensive care unit 2015 ·American Journal of Infection Control ·Elizabeth Gillespie, Natalie M. Williams, (unknown), Louise Wright, Despina Kotsanas, Rhonda L. Stuart	11
9	The role of ultraviolet marker assessments in demonstrating cleaning efficacy 2015 ·American Journal of Infection Control ·Elizabeth Gillespie, (unknown), Kylie Snook, (unknown), (unknown), (unknown), (unknown)	10
10	Microfiber and steam for environmental cleaning during an outbreak 2013 ·American Journal of Infection Control ·(unknown), Elizabeth Gillespie, Kylie Snook, Rhonda L. Stuart	13
11	Hand hygiene during the intensive care unit ward round: how much is enough? An observational study 2008 ·Critical Care and Resuscitation ·(unknown), Rhonda L. Stuart, Elizabeth Gillespie, Michael Buist	3
12	Microbiological monitoring of endoscopes: 5‐year review 2008 ·Journal of Gastroenterology and Hepatology ·Elizabeth Gillespie, Despina Kotsanas, Rhonda L. Stuart	40
13	Preparing for an influenza pandemic: healthcare workers’ opinions on working during a pandemic 2008 ·PubMed ·Rhonda L. Stuart, Elizabeth Gillespie	4
14	A sustained reduction in the transmission of methicillin-resistant Staphylococcus aureus in an intensive care unit 2007 ·Critical Care and Resuscitation ·Elizabeth Gillespie, (unknown), Rhonda L. Stuart, Michael Buist, Jill M. Wilson	1
15	1,3-Dihydro-2H-imidazo[4,5-b]quinolin-2-ones - inhibitors of blood platelet cAMP phosphodiesterase and induced aggregation 1991 ·Journal of Medicinal Chemistry ·Nicholas A. Meanwell, Hubert Roth, (unknown), (unknown), (unknown), John Fleming, Elizabeth Gillespie	26
16	Imidazoquinoline derivatives: Potent inhibitors of platelet cAMP phosphodiesterase which elevate cAMP levels and activate protein kinase in platelets 1991 ·Thrombosis Research ·Steven M. Seiler, Elizabeth Gillespie, (unknown), (unknown), Nicholas A. Meanwell, John Fleming	18
17	Pharmacology of a potent, new antithrombotic agent, 1,3-dihydro-7,8-dimethyl-2-imidazo[4,5-]quinolin-2-one (BMY-20844) 1989 ·Thrombosis Research ·(unknown), John Fleming, (unknown), (unknown), Elizabeth Gillespie, H.C. Stanton, Steven M. Seiler, (unknown)	11
18	Anagrelide: A potent and selective inhibitor of platelet cyclic AMP phosphodiesterase enzyme activity 1988 ·Biochemical Pharmacology ·Elizabeth Gillespie	41
19	Infection Risks of Haemodialysis—Some Preventive Aspects 1968 ·BMJ ·Yvonne E. Cossart, Elizabeth Gillespie, Dianne Jones, Janet Kelsey, Brian Moore, Iain R. Murray, Sheila Polakoff, Gregory G. Turner, (unknown), (unknown), Ragıp Atakan Al, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	16
20	Assessment of British Gammaglobulin in Preventing Infectious Hepatitis 1968 ·BMJ ·Yvonne E. Cossart, Elizabeth Gillespie, Daniel Jones, Janet Kelsey, Brian Moore, Iain R. Murray, Sheila Polakoff, G. Turner, (unknown), (unknown), Ragıp Atakan Al, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact